Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

XLOXLO
Showing 6 of 8 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in XILIO THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. previously held 0 shares of XLO (XILIO THERAPEUTICS INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$214,637

Total Shares Change

-272,486

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.65
0
2025-Q3
Unchanged
198,859
0.0%
$167,5780.0%$0.86
0
2025-Q2
Decreased
198,859
-21.8%
$135,2040.0%$0.68
0
2025-Q1
Decreased
254,346
-25.9%
$184,2480.0%$10.14
0
2024-Q4
Increased
343,230
+26.0%
$327,7850.0%$13.37
29
2024-Q3
Unchanged
272,486
0.0%
$214,6370.0%$11.03
0

Other major holders of XLO: RA CAPITAL MANAGEMENT, L.P., NORGES BANK, FIL Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used